Free Trial

The Cigna Group (CI) Competitors

$344.62
+13.62 (+4.11%)
(As of 05/31/2024 ET)

CI vs. ELV, HUM, CNC, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUE

Should you be buying The Cigna Group stock or one of its competitors? The main competitors of The Cigna Group include Elevance Health (ELV), Humana (HUM), Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.

The Cigna Group vs.

Elevance Health (NYSE:ELV) and The Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, community ranking, dividends, risk, institutional ownership, profitability and valuation.

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.6%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. The Cigna Group pays out 46.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 13 consecutive years and The Cigna Group has raised its dividend for 4 consecutive years.

The Cigna Group received 95 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.93% of users gave The Cigna Group an outperform vote while only 66.75% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
835
66.75%
Underperform Votes
416
33.25%
The Cigna GroupOutperform Votes
930
71.93%
Underperform Votes
363
28.07%

Elevance Health has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, The Cigna Group has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Elevance Health has higher earnings, but lower revenue than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.34B0.73$5.99B$26.4620.35
The Cigna Group$195.27B0.50$5.16B$12.1828.29

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 87.0% of The Cigna Group shares are held by institutional investors. 0.4% of Elevance Health shares are held by company insiders. Comparatively, 0.6% of The Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Elevance Health had 1 more articles in the media than The Cigna Group. MarketBeat recorded 24 mentions for Elevance Health and 23 mentions for The Cigna Group. Elevance Health's average media sentiment score of 0.95 beat The Cigna Group's score of 0.88 indicating that The Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
9 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Cigna Group
10 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.76%. The Cigna Group's return on equity of 20.62% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
The Cigna Group 1.76%17.24%5.09%

Elevance Health currently has a consensus price target of $598.23, suggesting a potential upside of 11.10%. The Cigna Group has a consensus price target of $373.87, suggesting a potential upside of 8.49%. Given The Cigna Group's higher possible upside, analysts plainly believe Elevance Health is more favorable than The Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
3.00
The Cigna Group
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
3.00

Summary

Elevance Health beats The Cigna Group on 13 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CI vs. The Competition

MetricThe Cigna GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$97.90B$65.58B$5.13B$17.79B
Dividend Yield1.69%1.39%2.75%3.55%
P/E Ratio28.2922.09167.1725.81
Price / Sales0.500.562,418.7811.40
Price / Cash9.249.7635.3018.95
Price / Book2.374.065.535.90
Net Income$5.16B$3.04B$106.01M$976.46M
7 Day Performance3.61%1.63%1.14%0.62%
1 Month Performance-3.49%13.97%1.43%4.79%
1 Year Performance35.98%24.07%4.07%24.00%

The Cigna Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.7689 of 5 stars
$538.46
+6.1%
$598.23
+11.1%
+15.9%$125.15B$171.34B20.35104,900Analyst Upgrade
Short Interest ↓
News Coverage
Gap Up
High Trading Volume
HUM
Humana
4.8176 of 5 stars
$358.25
+3.1%
$423.63
+18.3%
-30.5%$43.17B$106.37B22.3167,600Analyst Upgrade
Short Interest ↑
CNC
Centene
4.8155 of 5 stars
$71.57
+3.8%
$84.93
+18.7%
+10.2%$38.19B$154.00B14.2367,700Analyst Forecast
Options Volume
News Coverage
High Trading Volume
MOH
Molina Healthcare
4.9789 of 5 stars
$314.58
+2.8%
$407.45
+29.5%
+11.2%$18.43B$34.07B17.07123,123Analyst Forecast
News Coverage
High Trading Volume
UNH
UnitedHealth Group
4.9415 of 5 stars
$495.92
+3.0%
$572.75
+15.5%
+0.4%$456.44B$371.62B30.31440,000Analyst Forecast
News Coverage
OSCR
Oscar Health
2.6216 of 5 stars
$19.97
+0.6%
$18.57
-7.0%
+169.0%$4.74B$6.54B-49.922,400Analyst Forecast
Short Interest ↓
News Coverage
ALHC
Alignment Healthcare
2.9871 of 5 stars
$7.88
flat
$9.20
+16.8%
+33.6%$1.51B$2.01B-9.381,536Analyst Upgrade
Short Interest ↓
News Coverage
Positive News
High Trading Volume
TRUP
Trupanion
1.7456 of 5 stars
$29.87
-0.1%
$32.80
+9.8%
+32.6%$1.25B$1.11B-46.671,142Positive News
CLOV
Clover Health Investments
1.82 of 5 stars
$1.10
-3.5%
$1.50
+36.4%
+29.7%$546.08M$2.03B-3.24552Short Interest ↓
NEUE
NeueHealth
1.5187 of 5 stars
$6.00
-0.7%
$8.00
+33.3%
N/A$49.32M$1.16B-0.051,252Short Interest ↑
Negative News
Gap Down

Related Companies and Tools

This page (NYSE:CI) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners